Abstract

Permanent sterilization is the second most common contraceptive method used by women in the United States [1]. In 2002, a hysteroscopic permanent sterilization option was made available: The Essure® System. It consists of a set of 2 coil designated to induce fallopian tube fibrosis and subsequent tubal occlusion. Three months after placement, the tubal occlusion is confirmed with a hysterosalpingogram which will then ensuretubal blockage [2]. The coils could be inserted in an office setting with no anesthesia or only minor sedation, providing a safe alternative avoiding the need for surgical intervention. According to the FDA, Essure® sterilization is 99.8% effective at permanently preventing pregnancy over 5 years.